Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
FDA Says Class of Strong Antibiotics Should Be Used Sparingly
On July 26, the U.S. Food and Drug Administration (FDA) announced increased safety labeling requirements for a class of antibiotics called fluoroquinolones. These types of antibiotics ' including levofloxacin (Levaquin), ciprofloxacin (Cipro), ciprofloxacin extended-release tablets, moxifloxacin (Avelox), ofloxacin and gemifloxacin (Factive) ' are used for treating severe bacterial infections. However, they come with serious potential side-effects, such as muscle, joint and nerve damage. According to the FDA, these side-effects may show up hours or days after the drugs are taken, and their effects can be permanent. Because of this, the agency advised against the use of fluoroquinolones for garden-variety infections such as acute bacterial sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infections. Instead of reaching immediately for these stronger medications, the FDA says they should be used only when other treatments will not work ' the examples offered being anthrax, plague and bacterial pneumonia.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.
This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.